Back to Selection     Print       Date : 30 Jun 2025
Fund Summary
ITI Pharma and Healthcare Fund Reg (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 08-Nov-2021
Corpus(Cr.) 230.0 Latest NAV 16.8724 As on 29-07-2025
Equity(%) 97.26 52 Week High 17.6024
Debt(%) 2.74 52 Week Low 14.552
Others(%) 0.0 Exit Load -
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.35
Scheme Benchmark NIFTY Healthcare TRI. Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Rohan Korde
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 37.62%
Top 10 Holdings 56.05%
Top 25 Holdings 84.84%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 69.48
Healthcare 21.67
Cash 2.74
Fertilisers 2.58
Chemicals 1.92
Software & Services 1.29
SERVICES 0.32
 
 
 
 
 
Portfolio Metrics
PB Ratio 6.09
PE Ratio 31.00
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 11.99
DIVI LABORATORIES LTD. 9.03
Max Healthcare Institute Limited 6.12
Apollo Hospitals Enterprise Limited 5.35
Lupin Limited 5.13
Cohance Lifesciences Limited 4.53
Torrent Pharmaceuticals Limited 4.03
Aurobindo Pharma Limited 3.73
Aster DM Healthcare Limited 3.23
Wockhardt Limited 2.91
Mankind Pharma Limited 2.75
Net Receivables / (Payables) 2.74
Alkem Laboratories Limited 2.68
Abbott India Limited 2.62
Fortis Health Care Ltd 2.62
Neuland Laboratories Limited 2.08
Granules India Limited 1.89
FDC Limited 1.75
Healthcare Global Enterprises Limited 1.51
Vijaya Diagnostic Centre Limited 1.47
Sumitomo Chemical India Limited 1.43
Supriya Lifescience Limited 1.39
Rainbow Childrens Medicare Limited 1.37
Sagility India Limited 1.29
Dr Reddys Laboratories Limited 1.20

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
3.40% 6.36% 7.67% 8.91%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-3.02% 2.65% 8.02% 1.23%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
4.68% 7.93% 11.35% 10.43%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
24.29% 22.44% 0.00% 0.00%
 
 
13.76% 14.40% 18.66% 12.84%
 
 
25.89% 24.24% 20.45% 9.46%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
 
Back to Selection